Logo image of BGMS

BIO GREEN MED SOLUTION INC (BGMS) Stock Fundamental Analysis

USA - NASDAQ:BGMS - US23254L8761 - Common Stock

1.31 USD
-0.03 (-2.24%)
Last: 11/14/2025, 8:00:01 PM
1.27 USD
-0.04 (-3.05%)
After Hours: 11/14/2025, 8:00:01 PM
Fundamental Rating

3

Taking everything into account, BGMS scores 3 out of 10 in our fundamental rating. BGMS was compared to 533 industry peers in the Biotechnology industry. The financial health of BGMS is average, but there are quite some concerns on its profitability. While showing a medium growth rate, BGMS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BGMS has reported negative net income.
BGMS had a negative operating cash flow in the past year.
BGMS had negative earnings in each of the past 5 years.
In the past 5 years BGMS always reported negative operating cash flow.
BGMS Yearly Net Income VS EBIT VS OCF VS FCFBGMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

BGMS has a worse Return On Assets (-146.13%) than 84.05% of its industry peers.
BGMS has a Return On Equity of -177.11%. This is in the lower half of the industry: BGMS underperforms 64.92% of its industry peers.
Industry RankSector Rank
ROA -146.13%
ROE -177.11%
ROIC N/A
ROA(3y)-203.37%
ROA(5y)-137.74%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BGMS Yearly ROA, ROE, ROICBGMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

BGMS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BGMS Yearly Profit, Operating, Gross MarginsBGMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5K -10K -15K -20K -25K

More info and screens

6

2. Health

2.1 Basic Checks

BGMS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BGMS has been increased compared to 1 year ago.
The number of shares outstanding for BGMS has been increased compared to 5 years ago.
BGMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BGMS Yearly Shares OutstandingBGMS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10K 20K 30K
BGMS Yearly Total Debt VS Total AssetsBGMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -143.74, we must say that BGMS is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -143.74, BGMS is not doing good in the industry: 96.44% of the companies in the same industry are doing better.
BGMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -143.74
ROIC/WACCN/A
WACC8.78%
BGMS Yearly LT Debt VS Equity VS FCFBGMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M 30M

2.3 Liquidity

A Current Ratio of 5.77 indicates that BGMS has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 5.77, BGMS is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
A Quick Ratio of 5.77 indicates that BGMS has no problem at all paying its short term obligations.
BGMS has a better Quick ratio (5.77) than 61.73% of its industry peers.
Industry RankSector Rank
Current Ratio 5.77
Quick Ratio 5.77
BGMS Yearly Current Assets VS Current LiabilitesBGMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

4

3. Growth

3.1 Past

BGMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 96.85%, which is quite impressive.
Looking at the last year, BGMS shows a very negative growth in Revenue. The Revenue has decreased by -87.50% in the last year.
EPS 1Y (TTM)96.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.43%
Revenue 1Y (TTM)-87.5%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

Based on estimates for the next years, BGMS will show a very strong growth in Earnings Per Share. The EPS will grow by 57.16% on average per year.
Based on estimates for the next years, BGMS will show a very strong growth in Revenue. The Revenue will grow by 1049.89% on average per year.
EPS Next Y39.49%
EPS Next 2Y19.4%
EPS Next 3Y57.16%
EPS Next 5YN/A
Revenue Next Year88.68%
Revenue Next 2Y37.36%
Revenue Next 3Y1049.89%
Revenue Next 5YN/A

3.3 Evolution

BGMS Yearly Revenue VS EstimatesBGMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2018 2023 2024 2025 2026 2027 20M 40M 60M 80M
BGMS Yearly EPS VS EstimatesBGMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -10K -20K -30K -40K -50K

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BGMS. In the last year negative earnings were reported.
Also next year BGMS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BGMS Price Earnings VS Forward Price EarningsBGMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BGMS Per share dataBGMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60 -80 -100

4.3 Compensation for Growth

A more expensive valuation may be justified as BGMS's earnings are expected to grow with 57.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.4%
EPS Next 3Y57.16%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BGMS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BIO GREEN MED SOLUTION INC

NASDAQ:BGMS (11/14/2025, 8:00:01 PM)

After market: 1.27 -0.04 (-3.05%)

1.31

-0.03 (-2.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-10 2025-11-10
Earnings (Next)03-31 2026-03-31/amc
Inst Owners1.06%
Inst Owner ChangeN/A
Ins Owners63.57%
Ins Owner Change11.22%
Market Cap4.58M
Revenue(TTM)10.00K
Net Income(TTM)-6.43M
Analysts43.33
Price TargetN/A
Short Float %13.71%
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.03
Dividend Growth(5Y)-37.21%
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-100%
Min Revenue beat(2)-100%
Max Revenue beat(2)-100%
Revenue beat(4)1
Avg Revenue beat(4)-50.98%
Min Revenue beat(4)-100%
Max Revenue beat(4)96.08%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 458.5
P/FCF N/A
P/OCF N/A
P/B 1.26
P/tB 1.26
EV/EBITDA N/A
EPS(TTM)-122.08
EYN/A
EPS(NY)-1.14
Fwd EYN/A
FCF(TTM)-2.49
FCFYN/A
OCF(TTM)-2.49
OCFYN/A
SpS0
BVpS1.04
TBVpS1.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -146.13%
ROE -177.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-203.37%
ROA(5y)-137.74%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.77
Quick Ratio 5.77
Altman-Z -143.74
F-Score3
WACC8.78%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)96.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.43%
EPS Next Y39.49%
EPS Next 2Y19.4%
EPS Next 3Y57.16%
EPS Next 5YN/A
Revenue 1Y (TTM)-87.5%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next Year88.68%
Revenue Next 2Y37.36%
Revenue Next 3Y1049.89%
Revenue Next 5YN/A
EBIT growth 1Y48.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y57.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y57.05%
OCF growth 3YN/A
OCF growth 5YN/A

BIO GREEN MED SOLUTION INC / BGMS FAQ

What is the ChartMill fundamental rating of BIO GREEN MED SOLUTION INC (BGMS) stock?

ChartMill assigns a fundamental rating of 3 / 10 to BGMS.


What is the valuation status for BGMS stock?

ChartMill assigns a valuation rating of 1 / 10 to BIO GREEN MED SOLUTION INC (BGMS). This can be considered as Overvalued.


How profitable is BIO GREEN MED SOLUTION INC (BGMS) stock?

BIO GREEN MED SOLUTION INC (BGMS) has a profitability rating of 0 / 10.


What is the expected EPS growth for BIO GREEN MED SOLUTION INC (BGMS) stock?

The Earnings per Share (EPS) of BIO GREEN MED SOLUTION INC (BGMS) is expected to grow by 39.49% in the next year.